mitoxantrone has been researched along with Lung Diseases, Interstitial in 3 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-one patients with ovarian cancer who had failed chemotherapy were treated, 24 at the MTD." | 6.68 | A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma. ( Baldwin, P; Buckner, CD; Greco, FA; Hainsworth, JD; Lewis, M; Schwartzberg, L; Weaver, CH; West, WH; Wittlin, F; Zhen, B, 1997) |
| "Thirty-one patients with ovarian cancer who had failed chemotherapy were treated, 24 at the MTD." | 2.68 | A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma. ( Baldwin, P; Buckner, CD; Greco, FA; Hainsworth, JD; Lewis, M; Schwartzberg, L; Weaver, CH; West, WH; Wittlin, F; Zhen, B, 1997) |
| "We describe two cases of interstitial lung disease in patients with non-Hodgkin's lymphoma who were treated with combination chemotherapy including mitozantrone." | 1.30 | Interstitial pneumonitis following mitozantrone, chlorambucil and prednisolone (MCP) chemotherapy. ( Johnson, S; Nicholson, AG; Rule, S; Stone, R; Tighe, M; Tomlinson, J, 1999) |
| " An increase in the prednisolone dosage led to an improvement." | 1.29 | Interstitial pneumonitis possibly due to mitoxantrone. ( Aiso, M; Hagiwara, T; Hayama, T; Horie, T; Kitami, Y; Matsukawa, Y; Ohshima, T; Takeuchi, J, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsukawa, Y | 1 |
| Takeuchi, J | 1 |
| Aiso, M | 1 |
| Hagiwara, T | 1 |
| Hayama, T | 1 |
| Ohshima, T | 1 |
| Horie, T | 1 |
| Kitami, Y | 1 |
| Weaver, CH | 1 |
| Greco, FA | 1 |
| Hainsworth, JD | 1 |
| Zhen, B | 1 |
| Baldwin, P | 1 |
| Wittlin, F | 1 |
| Lewis, M | 1 |
| West, WH | 1 |
| Schwartzberg, L | 1 |
| Buckner, CD | 1 |
| Tomlinson, J | 1 |
| Tighe, M | 1 |
| Johnson, S | 1 |
| Stone, R | 1 |
| Nicholson, AG | 1 |
| Rule, S | 1 |
1 trial available for mitoxantrone and Lung Diseases, Interstitial
| Article | Year |
|---|---|
A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Carbo | 1997 |
2 other studies available for mitoxantrone and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Interstitial pneumonitis possibly due to mitoxantrone.
Topics: Adult; Female; Humans; Leukemia, Myeloid, Accelerated Phase; Lung Diseases, Interstitial; Mitoxantro | 1993 |
Interstitial pneumonitis following mitozantrone, chlorambucil and prednisolone (MCP) chemotherapy.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; H | 1999 |